Recursion Pharmaceuticals Inc banner

Recursion Pharmaceuticals Inc
NASDAQ:RXRX

Watchlist Manager
Recursion Pharmaceuticals Inc Logo
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
Watchlist
Price: 3.25 USD -3.56% Market Closed
Market Cap: $1.7B

Wall Street
Price Targets

RXRX Price Targets Summary
Recursion Pharmaceuticals Inc

Wall Street analysts forecast RXRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RXRX is 7.14 USD with a low forecast of 3.03 USD and a high forecast of 11.55 USD.

Lowest
Price Target
3.03 USD
7% Downside
Average
Price Target
7.14 USD
120% Upside
Highest
Price Target
11.55 USD
255% Upside
Recursion Pharmaceuticals Inc Competitors:
Price Targets
NCSM
NCS Multistage Holdings Inc
-26% Downside
ELAN
Elanco Animal Health Inc
13% Upside
FBIZ
First Business Financial Services Inc
33% Upside
SHLS
Shoals Technologies Group Inc
79% Upside

Revenue
Forecast

80% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss
80% / Year
Past Growth
27% / Year
Estimated Growth
Estimates Accuracy
-18%
Average Miss

For the last 5 years the compound annual growth rate for Recursion Pharmaceuticals Inc's revenue is 80%. The projected CAGR for the next 3 years is 27%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RXRX's stock price target?
Price Target
7.14 USD

According to Wall Street analysts, the average 1-year price target for RXRX is 7.14 USD with a low forecast of 3.03 USD and a high forecast of 11.55 USD.

What is Recursion Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
27%

For the last 5 years the compound annual growth rate for Recursion Pharmaceuticals Inc's revenue is 80%. The projected CAGR for the next 3 years is 27%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett